Effects of thyroxine replacement on lipid profile and endothelial function after thyroidectomy

Area of Science:

• Endocrinology
• Cardiovascular Medicine
• Thyroidology

Background:

• Hypothyroidism is a known risk factor for atherosclerotic cardiovascular disease.
• Transient hypothyroidism can occur post-thyroidectomy.
• The impact of L-thyroxine replacement on cardiovascular markers after thyroidectomy requires investigation.

Purpose of the Study:

• To investigate the effects of L-thyroxine replacement therapy on lipid profile and endothelial function.
• To assess cardiovascular risk markers in patients with transient hypothyroidism after thyroidectomy.

Main Methods:

• Study included 22 patients undergoing thyroidectomy and 22 healthy controls.
• Lipid profile and endothelial function were measured at four stages: pre-thyroidectomy, 3 weeks post-surgery (hypothyroid), and 3 and 6 months post-thyroxine treatment.
• Correlations between thyroid-stimulating hormone (TSH), lipid profile, and endothelial function were analyzed.

Main Results:

• Lipid profile and endothelial function deteriorated during the hypothyroid phase (3 weeks post-surgery) and persisted for 3 months.
• These functions returned to baseline levels by 6 months of L-thyroxine treatment.
• Elevated TSH correlated positively with total cholesterol and negatively with arterial dilatation, indicating TSH and cholesterol independently affect endothelial function.

Conclusions:

• A 3-week hypothyroid period post-thyroidectomy significantly worsens lipid profiles and endothelial function, contributing to atherogenesis.
• Impaired endothelial function and atherogenic lipid profiles persisted for at least 3 months despite L-thyroxine initiation.
• L-thyroxine replacement therapy is crucial for restoring cardiovascular health markers after thyroidectomy-induced hypothyroidism.